Struggling With Great Stock Picks? Discover StockInvest.us Top Gems!
$0.768
-0.0320 (-4.00%)
At Close: May 10, 2024
Forecast Earnings Fundamentals Insider Trading Signals Historical Prices Predictions News Profile

Range Low Price High Price Comment
30 days $0.700 $1.03 Friday, 10th May 2024 HOOK stock ended at $0.768. This is 4.00% less than the trading day before Thursday, 9th May 2024. During the day the stock fluctuated 9.46% from a day low at $0.740 to a day high of $0.81.
90 days $0.605 $1.03
52 weeks $0.410 $2.05

Historical Hookipa Pharma Inc. prices

Date Open High Low Close Volume
Dec 15, 2023 $0.685 $0.685 $0.650 $0.653 247 404
Dec 14, 2023 $0.660 $0.700 $0.654 $0.673 395 878
Dec 13, 2023 $0.650 $0.680 $0.650 $0.655 197 648
Dec 12, 2023 $0.690 $0.700 $0.643 $0.660 534 044
Dec 11, 2023 $0.590 $0.690 $0.580 $0.663 1 253 893
Dec 08, 2023 $0.589 $0.590 $0.575 $0.580 188 877
Dec 07, 2023 $0.584 $0.590 $0.575 $0.576 134 128
Dec 06, 2023 $0.592 $0.592 $0.570 $0.581 245 099
Dec 05, 2023 $0.588 $0.588 $0.563 $0.575 150 747
Dec 04, 2023 $0.580 $0.590 $0.551 $0.585 223 450
Dec 01, 2023 $0.570 $0.600 $0.550 $0.575 326 293
Nov 30, 2023 $0.580 $0.588 $0.550 $0.569 506 675
Nov 29, 2023 $0.520 $0.580 $0.520 $0.550 1 056 541
Nov 28, 2023 $0.550 $0.550 $0.491 $0.528 400 376
Nov 27, 2023 $0.504 $0.545 $0.504 $0.514 597 613
Nov 24, 2023 $0.497 $0.540 $0.480 $0.503 434 139
Nov 22, 2023 $0.459 $0.510 $0.445 $0.497 572 678
Nov 21, 2023 $0.519 $0.520 $0.451 $0.460 789 895
Nov 20, 2023 $0.540 $0.550 $0.471 $0.507 4 914 993
Nov 17, 2023 $0.461 $0.540 $0.461 $0.519 390 817
Nov 16, 2023 $0.465 $0.489 $0.460 $0.471 127 531
Nov 15, 2023 $0.484 $0.490 $0.470 $0.475 296 414
Nov 14, 2023 $0.470 $0.488 $0.450 $0.461 172 497
Nov 13, 2023 $0.500 $0.500 $0.450 $0.467 151 777
Nov 10, 2023 $0.477 $0.498 $0.440 $0.446 139 182
Click to get the best stock tips daily for free!

About Hookipa Pharma Inc.

Hookipa Pharma. HOOKIPA Pharma Inc., a clinical stage biopharmaceutical company, develops immunotherapeutics targeting infectious diseases and cancers based on its proprietary arenavirus platform. The company's lead infectious disease product candidate is HB-101, which is in a randomized double-blinded Phase II clinical trial in patients awaiting kidney transplantation from cytomegalovirus-positive donors. Its lead oncology product candidates are HB-201 and HB-2... HOOK Profile

Golden Star

Ticker Date Change Price
SXI May 08 2.97% $173.34
NVO May 08 1.37% $126.69
PAG May 07 1.42% $153.22
WMT May 06 1.02% $59.87
UNP May 06 3.42% $239.21
JPM May 06 3.53% $192.00
INGR May 03 4.94% $114.56
ASH May 03 2.28% $95.85
INVH May 03 1.13% $34.39
INTU May 03 0.483% $629.27
Unlock

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT